Ponatinib 45 mg Tablet is an advanced targeted therapy used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). It works by blocking specific proteins responsible for the uncontrolled growth of cancer cells.
| |||||||||||||||||||||
Ponatinib 45 mg Tablet Australia
Price range: $344.00 through $877.20
Out of stock
Reviews (1)
There are no reviews yet.